首页> 美国卫生研究院文献>Toxins >Development and Application of Extraction Methods for LC-MS Quantification of Microcystins in Liver Tissue
【2h】

Development and Application of Extraction Methods for LC-MS Quantification of Microcystins in Liver Tissue

机译:LC-MS定量测定肝组织中微囊藻毒素的提取方法的开发和应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A method was developed to extract and quantify microcystins (MCs) from mouse liver with limits of quantification (LOQs) lower than previously reported. MCs were extracted from 40-mg liver samples using 85:15 (v:v) CH CN:H O containing 200 mM ZnSO and 1% formic acid. Solid-phase extraction with a C18 cartridge was used for sample cleanup. MCs were detected and quantified using HPLC-orbitrap-MS with simultaneous MS/MS detection of the 135.08 fragment from the conserved Adda amino acid for structural confirmation. The method was used to extract six MCs (MC-LR, MC-RR, MC-YR, MC-LA, MC-LF, and MC-LW) from spiked liver tissue and the MC-LR cysteine adduct (MC-LR-Cys) created by the glutathione detoxification pathway. Matrix-matched internal standard calibration curves were constructed for each MC (R ≥ 0.993), with LOQs between 0.25 ng per g of liver tissue (ng/g) and 0.75 ng/g for MC-LR, MC-RR, MC-YR, MC-LA, and MC-LR-Cys, and 2.5 ng/g for MC-LF and MC-LW. The protocol was applied to extract and quantify MC-LR and MC-LR-Cys from the liver of mice that had been gavaged with 50 µg or 100 µg of MC-LR per kg bodyweight and were euthanized 2 h, 4 h, or 48 h after final gavage. C57Bl/6J (wild type, control) and Lepr /J (experiment) mice were used as a model to study non-alcoholic fatty liver disease. The Lepr /J mice were relatively inefficient in metabolizing MC-LR into MC-LR-Cys, which is an important defense mechanism against MC-LR exposure. Trends were also observed as a function of MC-LR gavage amount and time between final MC-LR gavage and euthanasia/organ harvest.
机译:开发了一种从小鼠肝脏中提取和定量微囊藻毒素(MC)的方法,其定量限(LOQ)低于以前报道的水平。使用含有200 mM ZnSO和1%甲酸的85:15(v:v)CH CN:H O从40 mg肝样品中提取MCs。使用C18柱进行固相萃取以净化样品。使用HPLC-orbitrap-MS检测并定量MC,同时从保守的Adda氨基酸中同时检测MS / MS 135.08片段,以进行结构确认。该方法用于从加标的肝脏组织和MC-LR半胱氨酸加合物(MC-LR-)中提取6种MC(MC-LR,MC-RR,MC-YR,MC-LA,MC-LF和MC-LW) Cys)由谷胱甘肽解毒途径产生。为每个MC(R≥0.993)构建与基质匹配的内标校准曲线,对于MC-LR,MC-RR,MC-YR,LOQ在0.25 ng / g肝组织(ng / g)和0.75 ng / g之间,MC-LA和MC-LR-Cys,对于MC-LF和MC-LW为2.5 ng / g。该方案适用于从小鼠肝脏中提取和定量MC-LR和MC-LR-Cys,这些小鼠已被每公斤体重50 µg或100 µg MC-LR灌胃,并在2 h,4 h或48次安乐死最终管饲后h。使用C57Bl / 6J(野生型,对照)和Lepr / J(实验)小鼠作为研究非酒精性脂肪肝疾病的模型。 Lepr / J小鼠在将MC-LR代谢为MC-LR-Cys方面效率相对较低,这是对抗MC-LR暴露的重要防御机制。还观察到趋势与MC-LR管饲量和最终MC-LR管饲与安乐死/器官收获之间的时间之间的函数关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号